PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.03%
Both yoy net incomes decline, with ORCL at -42.86%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.61%
Some D&A expansion while ORCL is negative at -0.53%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-83.45%
Negative yoy deferred tax while ORCL stands at 96.89%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
6.05%
Less SBC growth vs. ORCL's 13.20%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
130.75%
Less working capital growth vs. ORCL's 9137.93%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
200.20%
AR growth well above ORCL's 210.52%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-396.46%
Negative yoy inventory while ORCL is 287.10%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-143.28%
Both negative yoy AP, with ORCL at -249.17%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-165.97%
Negative yoy usage while ORCL is 238.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
103.42%
Lower 'other non-cash' growth vs. ORCL's 361.54%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-14.22%
Negative yoy CFO while ORCL is 35.69%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
16.44%
CapEx growth well above ORCL's 6.54%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-64.41%
Negative yoy acquisition while ORCL stands at 93.94%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-51.47%
Both yoy lines negative, with ORCL at -140.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
103.41%
Proceeds from sales/maturities above 1.5x ORCL's 53.87%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
170.80%
Growth well above ORCL's 52.95%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
75.53%
Investing outflow well above ORCL's 56.67%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-150.00%
We cut debt repayment yoy while ORCL is 61.11%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
38.64%
We slightly raise equity while ORCL is negative at -54.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-6.02%
We cut yoy buybacks while ORCL is 12.41%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.